3 Stocks Estimated To Be Trading At Discounts Of Up To 30.8%

As the U.S. stock market grapples with volatility, highlighted by a significant drop in major indices like the Dow Jones and S&P 500 amid tech sector declines and tariff uncertainties, investors are increasingly on the lookout for opportunities amidst the turbulence. In such an environment, identifying stocks trading at substantial discounts can offer potential value, especially when these companies possess strong fundamentals that may not be reflected in their current valuations.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Udemy (UDMY)	$6.86	$13.24	48.2%
SolarEdge Technologies (SEDG)	$33.82	$67.55	49.9%
Phibro Animal Health (PAHC)	$37.07	$70.71	47.6%
Peapack-Gladstone Financial (PGC)	$29.01	$56.54	48.7%
Northwest Bancshares (NWBI)	$12.65	$24.41	48.2%
Lyft (LYFT)	$16.22	$31.03	47.7%
Investar Holding (ISTR)	$23.44	$45.84	48.9%
Fiverr International (FVRR)	$23.55	$45.46	48.2%
Excelerate Energy (EE)	$24.42	$46.63	47.6%
Corsair Gaming (CRSR)	$8.93	$17.80	49.8%

Click here to see the full list of 196 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

Oddity Tech (ODD)

Overview: Oddity Tech Ltd. is a consumer tech company that creates digital-first brands for the beauty and wellness sectors both in the United States and internationally, with a market cap of $3.36 billion.

Operations: The company's revenue is primarily derived from its Personal Products segment, which generated $751.85 million.

Estimated Discount To Fair Value: 23.3%

Oddity Tech is trading at US$60.21, which is 23.3% below its estimated fair value of US$78.53, suggesting potential undervaluation based on cash flows. Recent earnings reports show solid growth with Q2 sales rising to $241.14 million from $192.77 million year-over-year and net income increasing to $49.29 million from $45.49 million a year ago, while revenue and earnings are forecasted to grow faster than the US market average.

• According our earnings growth report, there's an indication that Oddity Tech might be ready to expand.
• Click here and access our complete balance sheet health report to understand the dynamics of Oddity Tech.

Blackbaud (BLKB)

Overview: Blackbaud, Inc. provides cloud software and services both in the United States and internationally, with a market cap of approximately $3.18 billion.

Operations: The company's revenue primarily stems from its Software & Programming segment, which generated $1.14 billion.

Estimated Discount To Fair Value: 22.6%

Blackbaud is trading at US$66.71, over 20% below its estimated fair value of US$86.14, indicating potential undervaluation based on cash flows. Despite high debt levels, the company raised its 2025 revenue guidance to US$1.12 billion-US$1.13 billion and reported Q2 net income growth to US$25.98 million from US$21.8 million year-over-year, with earnings expected to grow significantly in the coming years and return on equity forecasted to be robust at 27.5%.

• In light of our recent growth report, it seems possible that Blackbaud's financial performance will exceed current levels.
• Click here to discover the nuances of Blackbaud with our detailed financial health report.

Inspire Medical Systems (INSP)

Overview: Inspire Medical Systems, Inc. is a medical technology company that develops and commercializes minimally invasive solutions for obstructive sleep apnea, with a market cap of approximately $2.77 billion.

Operations: The company's revenue is primarily derived from its Patient Monitoring Equipment segment, which generated $861.31 million.

Estimated Discount To Fair Value: 30.8%

Inspire Medical Systems, trading at US$93.69, is 30.8% below its fair value estimate of US$135.45, suggesting undervaluation based on cash flows despite a volatile share price and a recent CFO transition announcement. Earnings are forecast to grow significantly at 30.5% annually over the next three years, outpacing the US market's growth rate of 15.1%. The company has initiated a share repurchase program worth up to US$200 million and reaffirmed its full-year revenue guidance between US$900 million and US$910 million for 2025.

• Our expertly prepared growth report on Inspire Medical Systems implies its future financial outlook may be stronger than recent results.
• Dive into the specifics of Inspire Medical Systems here with our thorough financial health report.

Turning Ideas Into Actions

• Reveal the 196 hidden gems among our Undervalued US Stocks Based On Cash Flows screener with a single click here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com